�?�?名: | ||
---|---|---|
�?�p?人: | ||
�?nbsp; 别: | ||
�?nbsp; 码: | ||
重复密码�Q?/th> | ||
电子邮箱�Q?/th> | ||
邮箱验证码: | ||
固定电话�Q?/th> | ||
�?nbsp; 真: | ||
�?nbsp; 机: | ||
单位名称�Q?/th> | ||
通信地址�Q?/th> | ||
首选栏目: | ||
我已�l�认真阅��dƈ同意《健��L��服务条款�?/a> | ||
���定注册 |
健康�|�讯�Q?/FONT>
【报告名�U�】:药品市场�l�构报告�Q?018版) 【报告类别】:�q�度产品报告 【完成日期】:2018�q?�? 【报告格式】:电子版、报告全文纸�?彩色) 【交付方式】:EMAIL电子版或EMS印刷�?nbsp; 【�h 根{��:�K?8000 【联�pȝ��话】:010-68012929-2103/2121 雷先�?王小�?nbsp; ����? 中国医药市场�l�过多年的迅速增长,总规模上辑ֈ�了一个新的台�Ӟ�� �q�将在庞大的、迅速老龄化的人口�l�构和需求基���上,保持快速扩容,从增 镉K��度和未来潜力上�Q�将成�ؓ吸引全世界医药企业重点开发的市场�? 2017�q�_��规模以上医药企业主营业务收入亿元�Q�同比增�?�Q? 增速较2016�q�提�?.3个百分点�Q�恢复至两位数增�ѝ��中国医药工业各个子�? 业中�Q�化学制剂行业和中成药的比重�Q�已计超�q�了一半多的䆾�?�E�中�? �q�;增长最快的是化学原料药和中药饮片制造业�? 在利润总额�l�计昄����Q�随着新版药品GMP认证工作接近���֣��Q�一致性评�? �{���品质量提升工作加速推�q�和医药产业�l�构调整不断深化�Q?017�q�规模以 上企业实现利润总额亿元�Q�同比增�?�Q�增速提�?.0个百分点。利�? 增速高于主营业务收入增速,行业整体盈利水��^得到提高。增长最快的是生�? 药品刉���业和化学药品制剂制造业�Q���业发展动力不断向高附加��g�品�{�U�R�? 在新版GMP的严格推�q�,环保监管的严厉要求下�Q�国内医药领域的各项�? 度改革政�{�也在不断推出,包括药品定�h的放开、处方药�|�上销售、新的招 标方案、公立医院改革等�Q�从2015�q�上半年来看�Q�医药经���指标处于下行的 压力之下。医药经���进入新常态,变革孕育��Z���?/pre>本报告是我公�?-北京东方比特�U�技有限公司自主开发的市场研究报告�Q�是�?br/>识��权的唯一拥有者;现有一些非授权�|�站或机构盗版销售报告,我公司将�?br/>法追�I�其法律责�Q。敬请广大用戯��L别真伪,�Ƣ迎来电咨询�?/span>
�?�?/p>
一、医药市�����模概�q?............................................1
1�?015�?017�q�整体医院市场抽样销售额及增长趋�?...................3
2�?015�?017�q�各大类药物份额�Ҏ���Q?4大类�Q?.......................4
3�?016�?017�q�重�Ҏ��疗领域药物䆾额对�?...........................6
4�?017�q�药品市场销售排名前200位���?..........................8
5�?016�?017�q�用药额增长率最快的30个类�?........................14
6�?016�?017�q�增长率最快的通用名药�?............................15
二、市场结构(大类�ȝ��领域�Q?.......................................18
1�?全��n用抗感染�c�药物重点��品销售统�?...........................18
1.1�?017�q�全�w�用抗细菌类竞争品种份额...........................20
1.2�?017�q�全�w�用抗病毒类竞争品种�?0位䆾�?....................22
1.3�?017�q�全�w�用抗真菌类竞争品种�?0位䆾�?....................23
1.4�?017�q�全�w�用抗分枝菌�cȝ��争品�U�前20位䆾�?..................24
2�?017�q�抗肿瘤药物竞争品种份额...................................25
3�?017�q�免疫兴奋剂竞争品种份额...................................27
4�?017�q�心血���系�l�重点��品销售统�?..............................29
4.1�?017�q�抗高血压药物竞争品�U�前20位䆾�?......................29
4.2�?017�q�心肌营��d��保护药竞争品�U�䆾�?........................30
4.3�?017�q�周围血���扩张药竞争品种�?0位䆾额增长率...............30
4.4�?017�q�降血脂药物竞争品�U�前20位䆾�?........................31
4.5�?017�q�抗心绞痛药物竞争品�U�䆾�?............................32
4.6�?017�q�抗心衰药竞争品�U�䆾�?................................32
4.7�?017�q�抗休克药竞争品�U�䆾�?................................33
4.8�?017�q�抗心律失常药物竞争品种份额...........................33
4.9�?017�q�利���药竞争品种前䆾�?................................33
4.10�?017�q�其他心血���类药物竞争品种�?0位䆾�?.................34
5�?017�q�消化系�l�用药竞争品�U�前20位䆾�?..........................34
5.1�?017�q�治疗消化性溃疡病和胃食道反流病药物竞争品�U�前20位䆾�?35
5.2�?017�q�抗酸药竞争品种份额...................................36
5.3�?017�q�止吐药和止恶心药竞争品�U�䆾�?........................36
5.4�?017�q�止泻药及肠道抗�?抗感染药竞争品种�?0位䆾�?.........37
5.5�?017�q�治疗功能性胃肠道疄���药物竞争品种份额.................38
5.6�?017�q�轻泻药竞争品种份额...................................38
5.7�?017�q�消化酶竞争品种份额...................................39
6�?017�q�免疫抑制剂竞争品种份额...................................39
7�?017中枢���经�pȝ��药物重点产品销售统�?..........................40
7.1�?017�q�益�����和抗抑郁�{�精���兴奋药竞争品种�?0位䆾�?........40
7.2�?017�q�麻醉剂竞争品种�?0位䆾�?............................41
7.3�?017�q�止痛药竞争品种�?0位䆾�?............................42
7.4�?017�q�抗�_����病药物竞争品�U�前20位䆾�?......................42
7.5�?017�q�镇静、催眠药物竞争品�U�前20位䆾�?....................43
7.6�?017�q�抗癫痫药物竞争品种�?0位䆾�?........................44
7.7�?017�q�抗帕金���氏病药物竞争品�U�䆾�?........................44
7.8�?017�q�其它神�l�系�l�药物竞争品�U�前20位䆾�?..................45
8、血液系�l�药物重点��品销售统�?..................................46
8.1�?017�q�血���代用品和输注液竞争品种�?0~20位䆾�?.............46
8.2�?017�q�抗血栓�Ş成药物竞争品�U�前20位䆾�?....................47
8.3�?017�q�止血药物竞争品种�?0位䆾�?..........................47
8.4�?017�q�抗贫血制剂竞争品种�?0位䆾�?........................48
9�?017�q�糖���病�ȝ��药物竞争品种�?0位䆾�?........................49
9.1�?017�q�口服降血�p�药竞争品种�?0位䆾�?......................49
9.2�?017�q�胰岛素及其�c�M��药物竞争品种�?0~20位䆾�?.............50
10�?017�q�肌�?骨骼�pȝ��药物竞争品种份额...........................51
11�?017�q�肝胆系�l�药物竞争品�U�前20位䆾�?.........................52
12�?017泌尿生殖�pȝ��药和性激素重点品�U�销售统�?...................53
12.1�?017�q�性激素及生殖�pȝ��调节剂竞争品�U�前20位䆾�?...........53
12.2�?017�q�前列腺增生�ȝ��药物竞争品种份额......................54
12.3�?017�q�妇�U�抗感染药和抗菌剂竞争品�U�前10~20位䆾�?..........54
13�?017�q�全�w�用�Ȁ素类制剂竞争品种份额............................55
14�?017�q�维生素�c�药物竞争品�U�前20位䆾�?.........................56
15�?017呼吸�pȝ���ȝ��药物重点品种销售统�?.........................57
15.1�?017�q�咳嗽治疗用药物竞争品种�?0位䆾�?...................57
15.2�?017�q�抗哮喘药物竞争品种�?0位䆾�?.......................58
15.3�?017�q�全�w�用抗组�����物竞争品�U�前20位䆾�?.................59
15.4�?017�q���E用制剂竞争品�U�䆾�?...............................60
15.5�?017�q�咽喉用制剂竞争品种份额..............................60
15.6�?017�q�其它呼吸系�l�药物竞争品�U�䆾�?.......................60
16�?017�q�口腔科用药竞争品种份额..................................61
17�?017�q�矿物质补充剂竞争品�U�前20位䆾�?.........................61
三�?017�q�主要竞争企业䆾额排�?.....................................62
1�?017�q�全�w�用抗感染类重点品种竞争企业份额.......................62
2�?017�q�抗肿瘤药物重点品种竞争企业份额...........................69
3�?017�q�血���代用品和输注液重点品种竞争企业份额...................71
4�?017�q�治疗消化性溃疡病和胃食道反流病药物重点品�U�竞争企业䆾�?..74
5�?017�q�止吐药和止恶心药重点品�U�竞争企业䆾�?....................76
6�?017�q�抗酸药重点品种竞争企业份额...............................78
7�?017�q�止泻药及肠道抗�?抗感染药重点品种竞争企业份额............79
8�?017�q�治疗功能性胃肠道疄���的药物重点品�U�竞争企业䆾�?..........80
9�?017�q�抗高血压药物重点品�U�竞争企业䆾�?........................81
10�?017�q�精���兴奋药重点品种竞争企业份额..........................84
11�?017�q�口服降血�p�药物重点品�U�竞争企业䆾�?.....................87
12�?017�q�胰岛素及类似物重点品种竞争企业份额......................89
13�?017�q�周围血���扩张药重点品种竞争企业份额......................90
14�?017�q�肝胆系�l�药物重点品�U�竞争企业䆾�?.......................91
15�?017�q�抗血栓�Ş成药物重点品�U�竞争企业䆾�?.....................93
16�?017�q�维生素�c�药物重点品�U�竞争企业䆾�?.......................95
17�?017�q�降血脂药物竞争品�U�前20位厂家䆾�?.......................96
18�?017�q�心肌营��d��保护药物重点品种竞争企业份额..................98
19�?017�q�止痛药物重点品�U�竞争企业䆾�?..........................100
20�?017�q�咳嗽用药重点品�U�竞争企业䆾�?..........................102
21�?017�q�止血药物重点品种竞争企业份额...........................104
22�?017�q�麻醉药物重点品�U�竞争企业䆾�?..........................106
23�?017�q�抗心绞痛药物重点品�U�竞争企业䆾�?......................108
24�?017�q�矿物质补充剂重点品�U�竞争企业䆾�?......................111
25�?017�q�抗哮喘药物重点品种竞争企业份额.........................112
26�?017�q�抗贫血制剂重点品种竞争企业份额.........................113
27�?017�q�抗心律失常药物重点品种竞争企业份额.....................116
28�?017�q�抗心衰药重点品�U�竞争企业䆾�?..........................118
29�?017�q�抗�_����病药物重点品�U�竞争企业䆾�?......................119
30�?017�q�全�w�用抗组�����物重点品�U�竞争企业䆾�?..................120
31�?017�q�镇静、催眠药物重点品�U�竞争企业䆾�?....................123
32�?017�q�抗癫痫药物重点品种竞争企业份额.........................124
33�?017�q�抗帕金���氏病药物重点品�U�竞争企业䆾�?..................126
34�?017�q���E用制剂重点品�U�竞争企业䆾�?..........................127
35�?017�q�抗休克药重点品�U�竞争企业䆾�?..........................128
36�?017�q�口腔科用药重点品种竞争企业份额.........................129
37�?017�q�其他心血���类药物重点品种竞争企业份额...................130
�?1 2013~2017�q�医药��业各子行业利润总额及增长率.................2
�?2 2013�?017�q�全国抽样医院药品销售额及增长率......................3
�?3 2015�?017�q?5大类药品抽样医院销售额及增长率....................4
�?4 2015�?013�q?5大类药品医院销售金额比�?.........................5
�?5 2016�?017�q�细分治疗领域医院用药额变化..........................6
�?6 2017�q�销售金额前200名药�?......................................8
�?7 2016�?017�q�用药䆾额在1%以上的细分治疗类增长率排�?............14
�?8 2016�?017�q�排名前100位药品的增长率对�?.......................15
�?9 2013-2017�q�抗感染�c�药物市��Z��额及增长�?.......................18
�?10 2013-2017�q�全�w�用抗细菌药市场份额及增长率.....................19
�?11 2017�q�全�w�用抗细菌类药品销售前100�?..........................20
�?12 2017�q�全�w�用抗病毒药产品排名及䆾�?...........................22
�?13 2017�q�全�w�用抗真菌药产品排名及䆾�?...........................23
�?14 2017�q�抗分枝杆菌药��品排名及份额..............................24
�?15 2017�q�抗肿瘤药物销售额排名....................................25
�?16 2017�q�免疫兴奋剂销售排序和份额................................27
�?17 2017�q�心血���系�l�药物大�c�M��额及排序............................29
�?18 2017�q�抗高血压药物销售前20�?.................................29
�?19 2017�q�心肌营��d��保护药物销售䆾额及排名........................30
�?20 2017�q�周围血���扩张药物销售前20�?.............................30
�?21 2017�q�降血脂药物销售前20�?...................................31
�?22 2017�q�抗心绞痛药物销售前20�?.................................32
�?23 2017�q�抗心衰药销售��品排�?...................................32
�?24 2017�q�抗休克药物销售排�?.....................................33
�?25 2017�q�抗心律失常药物销售前20�?...............................33
�?26 2017�q�利���药销售前20�?.......................................33
�?27 2017�q�其他心血���类药物销售前20�?.............................34
�?28 2017�q�消化系�l�用药销售前20�?.................................34
�?31 2017�q�治疗消化性溃疡病和胃食道反流病的药物销售前20�?.........35
�?32 2017�q�抗酸药销售排�?.........................................36
�?33 2017�q�止吐药和止恶心药销售排�?...............................36
�?32 2017�q�止泻药及肠道抗�?抗感染药销售前20�?....................37
�?33 2017�q�治疗功能性肠道疾病药物销售品�U?.........................38
�?34 2017�q�轻泻药销售品�U�䆾�?.....................................38
�?35 2017�q�消化酶销售品�U�䆾�?.....................................39
�?36 2012�q�免疫抑制剂销售前20�?...................................39
�?37 2017�q�中枢神�l�系�l�药物大�c�M��额及排序..........................40
�?38 2017�q�精���兴奋药物销售前20�?.................................40
�?39 2017�q�麻醉剂�c�药物销售前20�?.................................41
�?40 2017�q�止痛药物销售前20�?.....................................42
�?41 2017�q�抗�_����病药物竞争品�U�前20位销售额........................42
�?42 2017�q�镇静、催眠药物竞争品�U�前20位销售额......................43
�?43 2017�q�抗癫痫药物销售前20�?...................................44
�?44 2017�q�抗帕金���氏病药竞争品种销售额及排�?.....................44
�?45 2017�q�其它神�l�系�l�药物竞争品�U�销售额及排�?...................45
�?46 2017�q�血液系�l�药物大�c�M��额及排序..............................46
�?47 2012�q�血���代用品和输注液销售前20�?...........................46
�?48 2017�q�抗血栓�Ş成药物销售前20�?...............................47
�?49 2017�q�止血药物销售前20�?.....................................47
�?50 2017�q�抗贫血药物销售前20�?...................................48
�?51 2017�q�糖���病�ȝ��药物销售前20�?...............................49
�?52 2017�q�口服降血�p�药销售前20�?.................................49
�?53 2017�q�胰岛素及其�c�M��药物销售排�?.............................50
�?54 2017�q�抗炎和抗风湿药销售前20�?...............................51
�?55 2017�q�治疗骨病的药物品种排名和䆾�?...........................51
�?56 2017�q�肝胆系�l�药物销售前20�?.................................52
�?57 2017�q�泌���生�D�系�l�药和性激素大�c�M��额及排序....................53
�?58 2017�q�性激素及生殖�pȝ��调节剂销售前20�?.......................53
�?59 2017�q�前列腺增生�ȝ��药物销售品�U�䆾�?.........................54
�?60 2017�q�妇�U�抗感染药和抗菌剂销售前20�?.........................54
�?61 2017�q�垂体和下丘脑激素及�c�M��物排序和份额......................55
�?61 2017�q�全�w�用�Ȁ素类药物销售排序和份额..........................56
�?61 2017�q�降钙素和甲状腺素药销售排序和份额........................56
�?64 2017�q�维生素药物销售前20�?...................................56
�?65 2017�q�呼吸系�l�药物类别䆾额排�?...............................57
�?66 2017�q�咳嗽治疗药物销售前20�?.................................57
�?67 2017�q�抗哮喘药物销售前20�?...................................58
�?68 2017�q�全�w�用抗组�����物销售前20�?.............................59
�?69 2017�q���E用制剂��品销售排�?...................................60
�?70 2017�q�咽喉用药销售前20�?.....................................60
�?71 2017其他呼吸�pȝ��药物销售䆾�?.................................60
�?72 2017�q�口腔科用药销售前20�?...................................61
�?74 2017�q�矿物质补充剂销售前20�?.................................61
�?77 2017�q�哌拉西�?他唑巴坦厂家市场份额...........................62
�?78 2017�q�美�|�培南厂家市��Z���?...................................63
�?79 2017�q�左氧氟沙星厂家市场份额..................................63
�?80 2017�q�头孢哌�?舒巴坦厂家市��Z���?............................64
�?81 2017�q�莫西沙星厂家市��Z���?...................................65
�?82 2017�q�拉氧头孢厂家市��Z���?...................................66
�?83 2017�q�头孢他啶厂家市��Z���?...................................66
�?83 2017�q�头孢唑肟厂家市��Z���?...................................67
�?84 2017�q�头孢地���厂家市��Z���?...................................67
�?85 2017�q�抗肿瘤药主要销售企业所占市��Z���?.......................69
�?86 2017�q���杉醇�c�d��剂前20家所占䆾�?.............................70
�?86 2017�q�多西他赛制剂前20家所占䆾�?.............................70
�?92 2017�q�氯化钠竞争厂家�?0�?...................................71
�?93 2017�q��h白蛋白竞争厂家前20�?.................................72
�?94 2017�q�葡萄糖竞争厂家�?0�?...................................72
�?95 2017�q�丙氨酰��h�}酰胺竞争厂家�?0�?...........................73
�?96 2017�q���n托拉唑竞争厂家排名前20�?.............................74
�?97 2017�q�兰索拉唑竞争厂家排名前20�?.............................74
�?98 2017�q�奥���拉唑竞争厂家排�?...................................75
�?99 2017�q�雷贝拉唑竞争厂家排�?...................................75
�?100 2017�q�埃索美拉唑竞争厂家排名.................................76
�?101 2017�q�托烷司琼竞争厂家排�?..................................76
�?102 2017�q�帕�z�诺司琼竞争厂家排名.................................77
�?103 2017�q�昂丹司琼竞争厂家排�?..................................77
�?104 2017�q�多拉司琼竞争厂家排�?..................................77
�?105 2017�q�阿扎司琼竞争厂家排�?..................................77
�?106 2017�q�铝���酸镁竞争厂家排�?..................................78
�?107 2017�q�磷酔R��竞争厂家排名.....................................78
�?108 2017�q�铝镁加竞争厂家排名.....................................78
�?109 2017�q�铝镁二甲硅油竞争厂家排�?..............................79
�?110 2017�q�碳酸氢钠竞争厂家排�?..................................79
�?111 2017�q�美沙拉�U�竞争厂家排�?..................................79
�?112 2017�q�酵母菌竞争厂家排名.....................................79
�?113 2017�q�双歧杆�?嗜酸��x���?肠球菌三联活菌竞争厂家排�?........80
�?114 2017�q�复方嗜���^杆菌竞争厂家排名.............................80
�?115 2017�q�双歧杆�?��x���?嗜热铄���菌三联活菌竞争厂家排�?........80
�?116 2017�q�间苯三酚竞争厂家排�?..................................80
�?117 2017�q�莫沙必利竞争厂家排�?..................................80
�?118 2017�q�曲���布汀竞争厂家排名...................................81
�?119 2017�q�伊托必利竞争厂家排�?..................................81
�?120 2017�q�二甲硅油竞争厂家排�?..................................81
�?127 2017�q��}氯地�q�竞争厂家前20�?................................81
�?128 2017�q�缬沙坦竞争厂家�?0�?..................................82
�?129 2017�q�硝苯地�q�竞争厂家䆾�?..................................83
�?130 2017�q�氯沙坦竞争厂家�?0�?..................................83
�?131 2017�q�厄贝沙坦竞争厂家前20�?................................83
�?132 2017�q�左旋�}氯地�q�竞争厂家前20�?............................84
�?138 2017�q�奥拉西坦竞争厂家前20�?................................84
�?139 2017�q�长春西丁竞争厂家前20�?................................85
�?140 2017�q�胞���������q��争厂家前20�?................................85
�?141 2017�q�银杏叶制剂竞争厂家�?0�?..............................86
�?142 2017�q�艾司西酞普兰竞争厂家前20�?............................86
�?143 2017�q�多奈哌齐竞争厂家前20�?................................86
�?144 2017�q�阿卡�L�p�竞争厂家排�?..................................87
�?145 2017�q�二甲双胍竞争厂家排名前20�?............................87
�?146 2017�q�格列美脲竞争厂家排�?..................................88
�?147 2017�q�瑞格列奈竞争厂家排�?..................................88
�?148 2017�q�格列齐特竞争厂家排名前十位.............................89
�?149 2017�q�甘�_�胰岛素竞争厂家排名.................................89
�?150 2017�q�低�_�蛋白门冬胰岛素70/30竞争厂家排名....................89
�?151 2017�q�低�_�蛋白�h胰岛�?0/30竞争厂家排名......................89
�?152 2017�q�门冬胰岛素竞争厂家排名.................................90
�?153 2017�q�地特胰岛素竞争厂家排名.................................90
�?154 2017�q�桂哌齐特竞争厂家前20�?................................90
�?155 2017�q�丹参川芎嗪竞争厂家�?0�?..............................90
�?156 2017�q�参芎葡萄糖竞争厂家�?0�?..............................90
�?157 2017�q�丹参酮ⅡA���酸钠竞争厂家前20�?.........................91
�?158 2017�q�谷�U�注���液竞争厂家�?0�?..............................91
�?165 2017�q�核�p�核酸竞争厂家排�?..................................91
�?166 2017�q�异甘草酔R��竞争厂家排名.................................91
�?167 2017�q�复方甘草酸��L��争厂家排名前20�?........................91
�?168 2017�q�多烯磷脂酰胆碱竞争厂家排名.............................92
�?169 2017�q�熊��L��胆酸竞争厂家排名.................................92
�?175 2017�q�硫酸氯吡格��L��争厂家排�?..............................93
�?176 2017�q�低分子肝素钙竞争厂家前10�?............................93
�?177 2017�q�利伐沙班竞争厂家排�?..................................93
�?178 2017�q�依�����素竞争厂家排�?..................................94
�?179 2017�q�阿司匹林竞争厂家排�?..................................94
�?180 2017�q�骨化三醇竞争厂家排�?..................................95
�?181 2017�q�复方维生素(12)竞争厂家排名.............................95
�?182 2017�q�复合维生素B竞争厂家前二十位排名........................95
�?183 2017�q�复方脂溶性维生素竞争厂家排名...........................96
�?184 2017�q�复方维生素(3)竞争厂家排名..............................96
�?185 2017�q�阿托伐他汀竞争厂家�?0�?..............................96
�?186 2017�q�瑞舒伐他汀竞争厂家�?0�?..............................97
�?187 2017�q�匹伐他汀竞争厂家�?0�?................................97
�?188 2017�q�辛伐他汀竞争厂家�?0�?................................97
�?189 2017�q�氟伐他汀竞争厂家�?0�?................................98
�?190 2017�q�普伐他汀竞争厂家�?0�?................................98
�?191 2017�q�磷酸肌酸竞争厂家前20�?................................98
�?192 2017�q�复合辅酶竞争厂家前20�?................................99
�?193 2017�q�二丁酰环磷�����钙竞争厂家前20�?........................99
�?194 2017�q�泛癸利酮竞争厂家前20�?................................99
�?195 2017�q�二���酸果糖竞争厂家�?0�?.............................100
�?196 2017�q�三�������?氯化镁竞争厂家前20�?........................100
�?197 2017�q�地佐辛竞争厂家�?0�?.................................100
�?198 2017�q�羟考酮竞争厂家�?0�?.................................101
�?199 2017�q�丙帕他莫竞争厂家前20�?...............................101
�?200 2017�q�喷他佐辛竞争厂家前20�?...............................101
�?201 2017氨酚���考酮竞争厂家�?0�?...............................101
�?202 2017布托啡诺竞争厂家�?0�?.................................101
�?203 2017�q�吗啡竞争厂家前20�?...................................102
�?204 2012�q��}溴烦竞争厂家�?0�?.................................102
�?205 2017�q�溴己新竞争厂家�?0�?.................................103
�?206 2017�q�乙酰半胱�}酸竞争厂家前20�?...........................103
�?207 2017桉柠蒎竞争厂家前20�?...................................103
�?208 2017�q�福多司坦竞争厂家前20�?...............................104
�?209 2017�q�重�l��h血���板生成素竞争厂家排�?.......................104
�?210 2017�q�尖吻蝮蛇血凝酶竞争厂家排序............................104
�?211 2017�q�冻�q��h凝血因子Ⅷ竞争厂家排�?.........................104
�?212 2017�q�卡�l�磺钠竞争厂家前20�?...............................105
�?213 2017�q��}甲环酸竞争厂家前20�?...............................106
�?219 2017�q�异丙酚竞争厂家�?0�?.................................106
�?220 2017�q�七氟烷竞争厂家�?0�?.................................107
�?221 2017�q�瑞芬太���竞争厂家前20�?...............................107
�?222 2017�q�舒芬太���竞争厂家前20�?...............................107
�?223 2017�q�罗哌卡因竞争厂家前20�?...............................108
�?224 2017�q�单���酸异山梨酯竞争厂家销售额及排�?...................108
�?225 2017�q�曲���他嗪竞争厂家前20�?...............................109
�?226 2017�q�尼可地���竞争厂安���售额及排�?.........................109
�?227 2017�q�硝酸异山梨酯竞争厂安���售额及排�?.....................109
�?228 2017�q�硝酸甘油竞争厂安���售额及排�?.........................110
�?229 2017�q�碳酔R��D竞争厂家排名...................................111
�?230 2017�q�醋酔R��竞争厂家排名....................................111
�?231 2017�q�维D2������钙竞争厂家排�?...............................111
�?232 2017�q�维D钙竞争厂家排�?....................................111
�?233 2017�q�葡萄糖酔R��锌竞争厂家排�?.............................111
�?244 2017�q�布地奈��L��争企业销售额及排�?.........................112
�?245 2017�q�孟鲁司特竞争企业销售额及排�?.........................112
�?246 2017�q�布地奈��L��莫特�|�竞争企业销售额及排�?.................112
�?247 2017�q�多索茶���q��争企业销售额及排�?.........................112
�?248 2017�q�噻托溴�늫�争企业销售额及排�?.........................113
�?249 2017�q�甲钴胺竞争厂家�?0�?.................................113
�?250 2017�q�重�l��h促红素(CHO�l�胞�Q�竞争厂家排�?..................114
�?251 2017�q�腺苷钴胺竞争厂家排�?.................................114
�?252 2017�q�蔗�p�铁竞争厂家排名....................................115
�?253 2017�q�多�p�铁复合物竞争厂家排�?.............................115
�?254 2017�q�蛋白琥珀酔R��竞争厂家排名..............................115
�?255 2017�q�艾司洛���竞争厂家排�?.................................116
�?256 2017�q�胺���酮竞争厂家排名....................................116
�?257 2017�q�普�|�帕酮竞争厂家排�?.................................116
�?258 2017�q�普萘洛���竞争厂家排�?.................................117
�?259 2017�q�美西律竞争厂家排名....................................117
�?260 2017�q�米力农竞争厂家销售额及排�?...........................118
�?261 2017�q�重�l��h脑利钠肽竞争厂家销售额及排�?...................118
�?262 2017�q�环���酰苯���胺竞争厂安���售额及排�?.....................118
�?263 2017�q�左西孟旦竞争厂安���售额及排�?.........................119
�?264 2017�q��}力农竞争厂家销售额及排�?...........................119
�?265 2017�q�奥氮��^竞争厂家销售额及排�?...........................119
�?266 2017�q�喹�����^竞争厂家销售额及排�?...........................119
�?267 2017�q�阿立哌唑竞争厂安���售额及排�?.........................119
�?268 2017�q�利埚w��竞争厂家销售额及排�?...........................120
�?269 2017�q�帕利哌酮辛竞争厂家销售额及排�?.......................120
�?277 2017�q�地氯雷他定竞争厂家销售额及排�?.......................120
�?278 2017�q�依巴斯汀竞争厂家销售额及排�?.........................121
�?279 2017�q�西替利嗪竞争厂安���售额及排�?.........................121
�?280 2017�q�氯雷他定竞争厂安���售额及排�?.........................122
�?281 2017�q�左西替利嗪竞争厂家销售额及排�?.......................122
�?282 2017�q�卢帕他定竞争厂安���售额及排�?.........................123
�?288 2017�q�右���托咪定竞争厂家销售额及排�?.......................123
�?289 2017�q�咪辑֔�仑竞争厂安���售额及排�?.........................123
�?290 2017�q�唑吡坦竞争厂家销售额及排�?...........................123
�?291 2017�q�右佐匹克隆竞争厂家销售额及排�?.......................124
�?292 2017�q�艾司唑仑竞争厂安���售额及排�?.........................124
�?293 2017�q�丙戊酸钠竞争厂安���售额及排�?.........................124
�?294 2017�q�左乙拉西坦竞争厂家销售额及排�?.......................125
�?295 2017�q�奥卡西�q�竞争厂安���售额及排�?.........................125
�?296 2017�q�拉莫三嗪竞争厂安���售额及排�?.........................125
�?297 2017�q�普瑞巴林竞争厂安���售额及排�?.........................125
�?298 2017�q�普拉克索竞争厂安���售额及排�?.........................126
�?299 2017�q�多巴丝肼竞争厂安���售额及排�?.........................126
�?300 2017�q�溴隐亭竞争厂家销售额及排�?...........................126
�?301 2017�q�恩他卡朋竞争厂安���售额及排�?.........................126
�?302 2017�q�吡贝地���竞争厂安���售额及排�?.........................126
�?307 2017�q�莫�c�x��竞争厂家销售额及排�?...........................127
�?308 2017�q�异丙托溴铵竞争厂家销售额及排�?.......................127
�?309 2017�q�粉���螨竞争厂家销售额及排�?...........................127
�?310 2017�q���卓斯汀竞争厂家销售额及排�?.........................127
�?311 2017�q�氟替卡杄���争厂安���售额及排�?.........................127
�?312 2017�q�奥�z�他汀竞争厂家销售额及排�?.........................127
�?313 2017�q�去甲肾上腺素竞争厂安���售额及排�?.....................128
�?314 2017�q�多巴胺竞争厂家销售额及排�?...........................128
�?315 2017�q�间���胺竞争厂家销售额及排�?...........................128
�?316 2017�q�肾上腺素竞争厂安���售额及排�?.........................128
�?317 2017�q�复�Ҏ��己定竞争厂家排名................................129
�?318 2017�q�西吡氯�늫�争厂家排�?.................................129
�?319 2017�q�替���唑竞争厂家排名....................................129
�?320 2017�q�甲���唑竞争厂家排名....................................130
�?321 2017�q�聚�l�酮���竞争厂家排�?.................................130
�?322 2017�q�前列地���竞争厂安���售䆾额和排名........................130
�?323 2017�q�羟苯磺酔R��竞争厂家销售䆾额和排名......................130
�?324 2017�q�地奥司明竞争厂安���售䆾额和排名........................131
�?325 2017�q�草木犀���浸液竞争厂安���售䆾额和排名....................131
�?1 2017�q�国内医药市场各大类销售收入比�?...........................2
�?2 2000-2017�q�药品市场销售(按照商业口径�l�计�Q�规模(亿元�Q?....3
�?3 2013�?017�q�全国抽样医院药品销售额及增长趋�?...................4
�?4 2017�q?4大类�ȝ��药品医院销售金额比�?...........................6
�?5 2017�q�抗感染�c�药物市��Z��额(金额�Q?............................19
|
| |||||||
| |||||||